Israel's Gamida Cell raises $40 million for bone marrow trial

TEL AVIV (Reuters) - Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news